Business Context and Reporting Period
This Form 8-K Current Report was filed by SeaStar Medical Holding Corporation (ICU) on June 5, 2024. The filing reports a change in the composition of the Board of Directors, specifically the resignation of one director and the appointment of another.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Director Resignation: Mr. Andres Lobo resigned as a director of the Company, effective June 5, 2024.
- Director Appointment: Mr. John Neuman was appointed as a Class I director, effective immediately on June 5, 2024.
- Additional Board Elections: A press release dated June 10, 2024, announced the election of two additional board members, Ms. Jennifer A. Baird and Ms. Bernadette N. Vincent.
Management Commentary and Risks
The filing details the professional background of the new appointee, Mr. John Neuman. He retired from Dow Chemical Company in 2023 after 30 years of service, most recently as Vice President of Global Financial Accounting. His experience includes overseeing financial reporting for over 400 legal entities, managing M&A transactions (including the Rohm & Haas and Dow Corning acquisitions), and serving as a CPA. The filing does not disclose specific risks, contingencies, or unusual items related to operations.
Investor Verification Checklist
- Verify the full composition of the Board of Directors following the June 10, 2024 press release.
- Review the attached Exhibit 99.1 for details on the newly elected directors, Ms. Jennifer A. Baird and Ms. Bernadette N. Vincent.
- Confirm if the resignation of Mr. Andres Lobo was related to any undisclosed disagreements or events.
- Check subsequent filings for the Company's next scheduled financial report to assess operational performance.